Retinoids, vitamin C, niacinamide, peptides, sunscreen. The actives that have evidence, the actives that do not, and routine sequencing.
An evidence-first review of LLLT caps for pattern hair loss. Compares Capillus, iRestore, HairMax, and Theradome, analyzes RCT efficacy data, and maps LLLT's role in…
We analyze the photobiology and regulatory evidence of mineral vs. chemical sunscreens, FDA GRASE classifications, systemic absorption studies, iron oxides, and…
An evidence-first comparison of FDA-approved Latisse (bimatoprost) and OTC eyelash growth serums, detailing prostaglandin eye risks, class actions, and efficacy.
A clinical review of Microtox (MesoBotox). Discover how intradermal neuromodulator injections target receptors to reduce pore size and sebum, and review clinical trials.
Vitiligo is an autoimmune loss of pigment. The 2022 FDA approval of Opzelura (ruxolitinib) made it the first repigmentation drug — used alongside NB-UVB, excimer laser,…
Rosacea is treated by matching therapy to the feature that bothers you — redness, bumps, visible vessels, thickened skin, or eye symptoms. The evidence ladder for each,…
Sun spots (solar lentigines) are UV-driven pigment that fades well — once melanoma is ruled out. The evidence ladder: sunscreen, topicals, cryotherapy, peels, IPL, and…
Stretch marks affect most pregnant people and many teens. An evidence ladder — topicals, microneedling, RF, fractional laser — for early red vs mature white marks, with…
Only two drugs are FDA-approved for pattern hair loss, and both are decades old. An evidence-first guide to minoxidil, finasteride, dutasteride, and the 2026 pipeline…
What's safe during pregnancy and breastfeeding — Botox, fillers, laser hair removal, chemical peels, microneedling, and skincare actives. Based on published reviews, not…